Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032740

Chief Executive Officer sold 2,924 shares at $60.91 ($178,098)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2025-03-03 Sale 10b5-1 −2,924 $60.91 $178,098 3,019,411 I: show line 1 in the form
Open-market sales · 2,924 sh · avg $60.91 · $178,098

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BELANOFF JOSEPH K Chief Executive Officer 2025-02-28 Grant or award · Stock option (right to buy) 10b5-1 +350,000 350,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…